NCT06668454View on ClinicalTrials.gov

Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)

NARecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 9, 2025

Primary Completion Date

May 9, 2035

Study Completion Date

May 9, 2035

Conditions
Esophageal CancerGastric CancerOligometastatic Disease
Interventions
PROCEDURE

Surgical resection followed by preoperative chemoimmunotherapy for oligometastatic esophagogastric cancer

Surgical resection followed by preoperative chemoimmunotherapy for oligometastatic esophagogastric cancer

Trial Locations (1)

M5G 2C4

RECRUITING

Toronto General Hospital, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER